Sonia Quaratino MD, PhD

Dr. Sonia Quaratino joined Kymab in 2017 as Chief Medical Officer, responsible for the clinical strategy and execution of Kymab’s first-in-class and innovative programs in immunology and immuno-oncology through pre-clinical and early-stage clinical trials. Prior to that, she was Senior Medical Director in Oncology Early Clinical Development and Advisor in Immunology at Merck Serono in Darmstadt where she led Phase 1 and Phase 2 oncology and immuno-oncology clinical trials. She received her M.D. from the University of Palermo School of Medicine, completed her doctorate in hematology and oncology between the University of Palermo and Imperial College London and was awarded a PhD in Immunology at Imperial College.